Over the past 12 months, 0 insiders at Revance Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on RVNC: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 18, 24 | David HollanderCMO & Global Therapeutics Lead | SELL | 3.9K | $4.17 | $16K |
| Apr 16, 24 | Erica JordanChief Commercial Officer | SELL | 2.4K | $3.80 | $9K |
| Mar 18, 24 | Dwight MoxieCLO & GC | SELL | 8.1K | $5.04 | $41K |
| Mar 18, 24 | Tobin SchilkeCFO | SELL | 9.4K | $5.04 | $47K |
| Mar 18, 24 | Dustin S SjutsPresident | SELL | 9.2K | $5.04 | $46K |
| Mar 6, 24 | Mark J FoleyCEO | BUY | 30.0K | $6.98 | $209K |
| Sep 6, 23 | Dwight MoxieSVP, GC & Secretary | SELL | 11.0K | $17.06 | $188K |
| Sep 5, 23 | Dwight MoxieSVP, GC & Secretary | SELL | 23.9K | $17.81 | $425K |
| Aug 3, 23 | Mark J FoleyCEO | SELL | 26.3K | $22.57 | $593K |
| Jul 3, 23 | Mark J FoleyCEO | SELL | 26.3K | $24.94 | $655K |
| Jul 3, 23 | Tobin SchilkeCFO | SELL | 1.7K | $25.04 | $43K |
| Jun 15, 23 | Carey Oconnor KolajaDirector | SELL | 2.5K | $28.24 | $71K |
| Jun 9, 23 | Mark J FoleyCEO | SELL | 31.3K | $30.72 | $961K |
| Jun 9, 23 | Dustin S SjutsPresident | SELL | 5.0K | $30.82 | $154K |
| Jun 2, 23 | Tobin SchilkeCFO | SELL | 500 | $31.00 | $16K |
| Jun 1, 23 | Tobin SchilkeCFO | SELL | 2.7K | $30.57 | $83K |
| May 15, 23 | Mark J FoleyCEO | SELL | 70.4K | $34.55 | $2.4M |
| May 15, 23 | Dwight MoxieSVP, GC & Secretary | SELL | 21.4K | $34.55 | $739K |
| May 15, 23 | Tobin SchilkeCFO | SELL | 21.4K | $34.55 | $739K |
| May 15, 23 | Dustin S SjutsPresident | SELL | 21.0K | $34.55 | $726K |
| May 1, 23 | Tobin SchilkeCFO | SELL | 3.2K | $31.70 | $101K |
| Apr 3, 23 | Tobin SchilkeCFO | SELL | 3.2K | $32.15 | $103K |
| Mar 9, 23 | Mark J FoleyCEO | SELL | 70.4K | $31.59 | $2.2M |
| Mar 9, 23 | Dwight MoxieSVP, GC & Secretary | SELL | 18.5K | $31.59 | $584K |
| Mar 9, 23 | Tobin SchilkeCFO | SELL | 18.5K | $31.59 | $585K |
| Mar 9, 23 | Dustin S SjutsPresident | SELL | 21.5K | $31.59 | $679K |
| Mar 1, 23 | Tobin SchilkeCFO | SELL | 3.2K | $33.50 | $107K |
| Feb 1, 23 | Tobin SchilkeCFO | SELL | 3.2K | $34.60 | $111K |
| Jan 20, 23 | Tobin SchilkeCFO | SELL | 1.0K | $31.00 | $31K |
| Jan 9, 23 | Tobin SchilkeCFO | SELL | 1.7K | $28.00 | $43K |
| Sep 14, 22 | Dwight MoxieSVP, GC & Secretary | SELL | 11.0K | $27.07 | $298K |
| Dec 13, 21 | Angus C. RussellDirector | BUY | 6.4K | $15.74 | $101K |
| Dec 3, 21 | Aubrey RankinPresident, Innovation & Tech | BUY | 30.0K | $14.43 | $433K |
| Nov 29, 21 | Mark J FoleyCEO | BUY | 40.0K | $12.90 | $516K |
| Sep 27, 21 | Dwight MoxieSVP, GC & Secretary | SELL | 1.7K | $30.00 | $50K |
| Aug 16, 21 | Aubrey RankinPresident, Innovation & Tech | SELL | 9.4K | $26.34 | $247K |
| Jul 28, 21 | Aubrey RankinPresident, Innovation & Tech | SELL | 34.3K | $30.15 | $1.0M |
| Jul 26, 21 | Aubrey RankinPresident, Innovation & Tech | SELL | 55.4K | $29.72 | $1.6M |
Over the past 12 months, insiders at Revance Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on RVNC, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market RVNC insider purchase in our data was $516K by Mark J Foley, CEO, filed on Nov 29, 21.
0 different insiders at Revance Therapeutics, Inc. filed open-market SEC Form 4 transactions on RVNC over the last 12 months.
InsiderTape plots every RVNC insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Revance Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →